Expression of TRPC6 in benign and malignant human prostate tissues

Asian Journal of Andrology

Volumn 11, Issue 5, 2009, Pages 541-547

  Yue, Dan ^a   Wang, Yong ^a   Xiao, Jian Ying ^b   Wang, Ping ^a   Ren, Chang Shan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CANCER STAGING; CARCINOGENESIS; CARCINOMA; CONTROLLED STUDY; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEUROENDOCRINE CARCINOMA; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATE DISEASE; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; TRPC CATION CHANNELS;

EID: 70349162913     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2009.53     Document Type: Article

References (18)

1. Feldman BJ, Feldman D. The development of androgen-independent prostate cancer. Nat Rev Cancer 2001; 1: 34-45.
2. Venkatachalam K, Montell C. TRP channels. Ann Rev Biochem 2007; 76: 387-417.
3. 2+-selective cation channel TRPV6 in human prostate cancer: A novel prognostic marker for tumor progression. Oncogene 2003; 22: 7858-61.
4. 2+/NFAT-dependent pathways. Oncogene 2007; 26: 7380-5.
5. Zhang L, Barritt GJ. TRPM8 in prostate cancer cells: A potential diagnostic and prognostic marker with a secretory function? Endocr Relat Cancer 2006; 13: 27-38.
6. Yang ZH, Wang XH, Wang HP, Hu LQ. Effects of TRPM8 on the proliferation and motility of prostate cancer PC-3 cells. Asian J Androl 2009; 11: 157-65.
7. 2+ entry and proliferation of prostate cancer epithelial cells. Cancer Res 2006; 66: 2038-47.
8. Guilbert A, Dhennin-Duthille I, Hiani YE, Haren N, Khorsi H, et al Expression of TRPC6 channels in human epithelial breast cancer cells. BMC Cancer 2008; 8: 125.
9. El Boustany C, Bidaux G, Enfissi A, Delcourt P, Prevarskaya N, et al Capacitative calcium entry and transient receptor potential canonical 6 expression control human hepatoma cell proliferation. Hepatology 2008; 47: 2068-77.
10. Bodding M, Wissenbach U, Flockerzi V. Characterisation of TRPM8 as a pharmacophore receptor. Cell Calcium 2007; 42: 618-28.
11. Prevarskaya N, Zhang L, Barritt G. TRP channels in cancer. Biochim Biophys Acta 2007; 1772: 937-46.
12. Yang SL, Cao Q, Zhou KC, Feng YJ, Wang YZ. Transient receptor potential channel C3 contributes to the progression of human ovarian cancer. Oncogene 2009; 28: 1320-8.
13. 2+-permeable cationic channels in prostate cancer epithelial cells. J Clin Invest 2003; 111: 1691-701.
14. Rampino T, Gregorini M, Guidetti C, Broggini M, Marchini S, et al. KCNA1 and TRPC6 ion channels and NHE1 exchanger operate the biological outcome of HGF/scatter factor in renal tubular cells. Growth Factors 2007; 25: 382-91.
15. Nakashiro K, Hara S, Shinohara Y, Oyasu M, Kawamata H, et al. Phenotypic switch from paracrine to autocrine role of hepatocyte growth factor in an androgen-independent human prostatic carcinoma cell line, CWR22R. Am J Pathol 2004; 165: 533-40.
16. Nakashiro K, Okamoto M, Hayashi Y, Oyasu R. Hepatocyte growth factor secreted by prostate-derived stromal cells stimulates growth of androgen-independent human prostatic carcinoma cells. Am J Pathol 2000; 157: 795-803.
17. Hashem M, Essam T. Hepatocyte growth factor as a tumor marker in the serum of patients with prostate cancer. J Egypt Natl Canc Inst 2005; 17: 114-20.
18. Yasuda K, Nagakawa O, Akashi T, Fujiuchi Y, Koizumi K, et al. Serum active hepatocyte growth factor (AHGF) in benign prostatic disease and prostate cancer. Prostate 2009; 69: 346-51.